Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.
Multiple sclerosis during an emergency or crisis: A narrative review focused on the effect of war and COVID-19 pandemic.
Feasibility of a registry-integrated eHealth program for managing fatigue and cognitive problems in multiple sclerosis.
Microglia-mediated neuroinflammation and demyelination contribute to pain and social behavioral deficits after spared nerve injury.
Rewiring viral immunity and autoimmunity through neuroimmune circuits.
Distinct Regulatory DNA Methylation Signatures Across Multiple Sclerosis, Neuromyelitis Optica, and Neurological Post-Acute Sequelae of COVID-19.
Global, regional, and national burden of road injuries 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Effectiveness and Safety of Plasmapheresis in MOGAD Attacks: A Systematic Review and Meta-Analysis.
Tumefactive demyelinating disorders as neoplasm mimics: description of a typical case and literature review.
Erdheim-Chester Disease Presenting as Optic Neuritis: A Case Report and Review of the Literature.
Walking as a Window to the Brain: Redefining Gait in Neurology.
Disease Course After Anti-CD20 Discontinuation in Secondary Progressive Multiple Sclerosis-A Multicenter Long-Term Longitudinal Study.
Oligodendroglial TANGO2 Regulates Lipid Metabolism to Control Motor Coordination.
Unusual Sequential Development of Multiple Sclerosis, Thymoma, Myasthenia, and Lymphoma in the Same Patient.
A lightweight method for regression-based normalization of the cross-sectional area for cervical spinal cord atrophy assessment.
Vertical saccadic slowing is associated with fatigue in multiple sclerosis.
Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.
AQP4-IgG-positive myelitis occurring in a patient with small cell lung cancer: a case report.
Clinicians' and patients' perspectives of a mobility technician role in the hospital to promote ambulation: A qualitative study.
Seawater immersion reshapes the temporal dynamics of traumatic brain injury and reveals mitochondrial oxidative stress as a modifiable therapeutic target.
Rare adverse events after COVID-19 vaccination among Swedish older adults-evidence from a nationwide register-based study.
Primary Progressive Multiple Sclerosis With Acute Neurologic Deterioration Secondary to Metabolic Derangements and Medication Effects.
Recent Advances in Imaging of Demyelinating and Dysmyelinating White Matter Lesions.
Role of sirtuin 2 in the brain is cell-type and context-dependent: Implications for therapeutic targeting.
Identifying Risk Factors for the Rising Prevalence of Multiple Sclerosis in Saudi Arabia: A case-control analysis.
Pages
« first
‹ previous
…
1040
1041
1042
1043
1044
1045
1046
1047
1048
…
next ›
last »